[1] |
Martín M, Millan A, Ferraro F, et al. Leukocyte telomere length is associated with iron overload in male adults with hereditary hemochromatosis[J]. Biosci Rep, 2020, 40(10): BSR20201916. doi: 10.1042/BSR20201916
|
[2] |
Zhang L, Hou L, Liu Z, et al. A mitophagic response to iron overload-induced oxidative damage associated with the PINK1/Parkin pathway in pancreatic beta cells[J]. J Trace Elem Med Biol, 2020, 60: 126493. doi: 10.1016/j.jtemb.2020.126493
|
[3] |
Bahr TM, Christensen RD, Ward DM, et al. Ferritin in serum and urine: a pilot study[J]. Blood Cells Mol Dis, 2019, 76: 59-62. doi: 10.1016/j.bcmd.2019.02.001
|
[4] |
Pepe A, Pistoia L, Gamberini MR, et al. The close link of pancreatic iron with glucose metabolism and with cardiac complications in thalassemia major: a large, multicenter observational study[J]. Diabetes Care, 2020, 43(11): 2830-9. doi: 10.2337/dc20-0908
|
[5] |
Healy GM, Kannengiesser SAR, Espin-Garcia O, et al. Comparison of Inline R2* MRI versus FerriScan for liver iron quantification in patients on chelation therapy for iron overload: preliminary results[J]. Eur Radiol, 2021, 31(12): 9296-305. doi: 10.1007/s00330-021-08019-0
|
[6] |
Bas M, Gumruk F, Gonc N, et al. Biochemical markers of glucose metabolism may be used to estimate the degree and progression of iron overload in the liver and pancreas of patients with β-thalassemia major[J]. Ann Hematol, 2015, 94(7): 1099-104. doi: 10.1007/s00277-015-2342-y
|
[7] |
Lunova M, Schwarz P, Nuraldeen R, et al. Hepcidin knockout mice spontaneously develop chronic pancreatitis owing to cytoplasmic iron overload in acinar cells[J]. J Pathol, 2017, 241(1): 104-14. doi: 10.1002/path.4822
|
[8] |
Frazer DM, Wilkins SJ, Darshan D, et al. Stimulated erythropoiesis with secondary iron loading leads to a decrease in hepcidin despite an increase in bone morphogenetic protein 6 expression[J]. Br J Haematol, 2012, 157(5): 615-26. doi: 10.1111/j.1365-2141.2012.09104.x
|
[9] |
Wang XY, Zhang MZ, Woloshun RR, et al. Oral administration of ginger-derived lipid nanoparticles and Dmt1 siRNA potentiates the effect of dietary iron restriction and mitigates pre-existing iron overload in Hamp KO mice[J]. Nutrients, 2021, 13(5): 1686. doi: 10.3390/nu13051686
|
[10] |
Piolatto A, Berchialla P, Allegra S, et al. Pharmacological and clinical evaluation of deferasirox formulations for treatment tailoring[J]. Sci Rep, 2021, 11(1): 12581. doi: 10.1038/s41598-021-91983-w
|
[11] |
Vadolas J, Ng GZ, Kysenius K, et al. SLN124, a GalNac-siRNA targeting transmembrane serine protease 6, in combination with deferiprone therapy reduces ineffective erythropoiesis and hepatic iron-overload in a mouse model of β-thalassaemia[J]. Br J Haematol, 2021, 194(1): 200-10. doi: 10.1111/bjh.17428
|
[12] |
Takpradit C, Viprakasit V, Narkbunnam N, et al. Using of deferasirox and deferoxamine in refractory iron overload thalassemia[J]. Pediatr Int, 2021, 63(4): 404-9. doi: 10.1111/ped.14444
|
[13] |
Dai EY, Han L, Liu J, et al. Ferroptotic damage promotes pancreatic tumorigenesis through a TMEM173/STING-dependent DNA sensor pathway[J]. Nat Commun, 2020, 11(1): 6339. doi: 10.1038/s41467-020-20154-8
|